Introduction {#s1}
============

Neurological conditions in children can compromise the visual pathways and result in visual field (VF) changes with/without reduced visual acuity (VA) and/or impaired colour vision.[@R1]

There remains an incomplete evidence base regarding perimetry in the neuro-ophthalmological evaluation of children,[@R2] reflecting the challenges of performing an intensive task, requiring prolonged, steady fixation and prompt responses. In children without ophthalmic conditions, variations exist by approach in the minimum age for reliable testing and ability to detect specific defects.[@R3] Commonly, children with neuro-ophthalmic disease are assessed with kinetic perimetry to assess the full field, changes in VF shape/area, and delineate quadrant/hemifield defects whereas static perimetry has limited ability to detect subtle but important neuro-ophthalmic changes such as mild peripheral loss, slight nasal steps or subtle blind spot defects.

Goldmann perimetry is the established kinetic approach in children, but these perimeters are no longer commercially available.[@R12] Proposed replacements (by Takagi and Inami) lack evidence to inform their use. However, Octopus perimeters are increasingly used in practice, adopting 'Goldmann equivalent' stimuli for kinetic perimetry, automated stimuli presentation, and drawing on normative data for interpreting outputs in children.[@R13]

To improve the evidence base for clinicians making decisions about perimetry in children with neuro-ophthalmic disease, we investigated differences between Goldmann and Octopus kinetic perimetry in the context of a wider research programme (the Optimal Perimetric Testing in Children study) by comparing feasibility, quality and outputs.

Methods {#s2}
=======

We embedded this cross-sectional study within routine clinical care in our neuro-ophthalmology service at Great Ormond Street Hospital. Children aged 5--15 years, with either a diagnosed neuro-ophthalmic condition or known neuro-ophthalmic VF defect[@R1] were included to capture this heterogeneous population. For ethical and data quality considerations, children unable to perform perimetry, because they were systemically unwell or unable to comprehend or cooperate for other reasons, were not included.

Potential participants were identified by examining medical records and were approached during their scheduled hospital visit. Children and their parents were given information sheets and opportunities to ask questions about the study. Parents/guardians gave formal written consent, while children gave verbal assent.

VFs were measured using a Goldmann perimeter (Haag-Streit, Bern, Switzerland) and Octopus 900 (Haag-Streit) in a darkened clinic room, both by a single experienced orthoptist, who was unmasked to the participants' VF defect but had not previously tested them.

To prioritise continuity of care, test order was not randomised. Thus, Goldmann perimetry was performed first, followed by a 5 min rest period before Octopus perimetry. The right eye was assessed first unless contraindicated clinically. Before each test participants were given standardised age-appropriate instructions regarding fixation and responding to stimuli, and tested their buzzer.[@R14] After occlusion of one eye using a soft eye pad, they were aligned at the perimeter while sitting on a height adjustable chair.

Preparation time and any modifications necessary were recorded. Encouragement and repetition of instructions were given throughout. Rest breaks were offered and recorded if taken.

Refractive errors were corrected for isopter I2e only,[@R15] if greater than +3.00 dioptre spheres (DS), greater than −1.00 DS, or greater than 1.00 dioptre cylinder. Where applicable, choice of isopters was based on previous Goldmann perimetry, with identical isopters selected for Octopus perimetry. Participants without prior experience were assessed using isopters I4e and I2e. All tests started with plotting an outer, followed by inner isopter and then blind spot (I2e, stimulus speed of 2°/s), allowing accustomisation with easier stimuli.

Targets were presented along 12 cardinal meridia (every 30°, at 5°/s (automated for Octopus, approximated for Goldmann)), centripetally from a non-seeing area (manually defined start points), followed by further points, up to a maximum of 24 (ie, every 15°). For children with hemianopia, targets were presented centripetally for the seeing half of the field, but were presented every 15° along the y-axis, from non-seeing to seeing areas, for the non-seeing field.

Quality of each test was assessed using the Examiner Based Assessment of Reliability (EBAR),[@R14] which standardises the conventional qualitative clinical approach, taking account of comprehension of instructions, cooperation, fatigue, fixation and response to stimuli, to rate assessments as either 'good', 'fair' or 'poor' quality ([online supplementary etable 1](#SP2){ref-type="supplementary-material"}). We applied the quantitative kinetic perimetry reliability measure (KPRM)[@R16] of test-retest variability that uses the median value of the differences between four paired measurements: lower scores indicate better quality. Finally, children rated each test using a 5-point Likert scale ranging from 'very hard' to 'very easy' and any additional comments were recorded.
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Goldmann VF plots were digitised using Engauge Digitizer (open source, <http://www.digitizer.sourceforge.net>) and Goldmann and Octopus coordinates were extracted into matrices using the kineticF package[@R17] in R (The R Project for Statistical Computing; V.3.2.0, <http://www.r-project.org>). VF defects were graded by the same unmasked clinician using the adaptation of Wall and George's[@R18] classification system for children, but retaining information on blind spot defects.[@R19] Higher scores represent greater VF loss from mild isopter constriction of less than 10° (grade 1) to marked loss (grade 5---isopter V4e within 20°). Type of VF defect was categorised and compared.[@R20]

Statistical analysis {#s2-1}
--------------------

Data were hosted securely in a Research Electronic Data Capture database[@R21] at UCL and exported to STATA (StataCorp, V.12) for analysis.

Analysis of feasibility draws on all participants. Statistical comparisons of outputs only use data from participants with 'good EBAR' scores for both tests, that is, tests deemed representative of a subject's true VF sensitivity. Comparisons of test duration used paired t-tests and agreement between isopter area from each perimeter was analysed by the Bland-Altman method.[@R22] Agreement between VF loss severity scores was measured with linearly weighted kappa statistics (perfect agreement=1, with a decrease of 0.25 per level increase in disagreement).[@R23] EBAR quality ratings were compared using McNemar's test.[@R24]

Multivariable linear regression models were fitted to investigate the relationship between test duration and age (continuous variable) including only factors significant at a 10% level (two sided, p\<0.1) in univariable analyses, such as VA, isopter area (I4e), sex and ethnicity. Logistic regression models were fitted to investigate the relationship between EBAR and KPRM. Robust variance estimates were used to account for within-subject correlation (two eyes).[@R25]

Results {#s3}
=======

Thirty of 31 (96.8%) eligible children participated. The mean age of participants was 11.1 years (SD: 2.6), 12 (40%) were female and 22 were White (73.3%), with 3 Black, 4 Asian and 1 Mixed ethnicity child.

Twenty participants had prior experience of VF testing ranging from 1 to 8 years' experience (median=2 years (IQR: 1--3.5)), with a median of 1.25 tests (IQR: 1--2.1) per year. Median VA and spherical equivalent (averaged within subject, n=30) was 0.04 LogMAR (IQR: −0.08, 0.21) and 0.0 dioptre (IQR: 0.0, 0.56), respectively.

[Table 1](#T1){ref-type="table"} lists for all 30 participants, diagnosis, type of VF defect recorded by Goldmann, and agreement with Octopus, and grade of VF loss for Goldmann and Octopus perimetry.

###### 

Neuro-ophthalmic diagnoses, associated visual field (VF) defects and grade of VF loss for all 30 participants, ordered by increasing severity of VF loss

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Neuro-ophthalmic diagnosis                                                   Age (years)                                                                           Eye     Visual field defect\*                                                                 Matching type of VF defect?[@R20]   Grade of visual field loss using the modified Wall and George system[@R18]   
  ---------------------------------------------------------------------------- ------------------------------------------------------------------------------------- ------- ------------------------------------------------------------------------------------- ----------------------------------- ---------------------------------------------------------------------------- ----
  Idiopathic intracranial hypertension (IIH)                                   7                                                                                     Right   Normal visual field                                                                   Yes                                 0                                                                            0

  Left                                                                         Normal visual field                                                                   Yes     0                                                                                     0                                                                                                                

  Suprasellar cyst\                                                            7                                                                                     Right   Normal visual field                                                                   Yes                                 0                                                                            0
  Hydrocephalus with VP shunt                                                                                                                                                                                                                                                                                                                                                       

  Left                                                                         Normal visual field                                                                   Yes     0                                                                                     0                                                                                                                

  Bilateral discrete white matter lesions                                      7                                                                                     Right   Normal visual field (previously found to have a nasal step)                           Yes                                 0                                                                            0

  Left                                                                         Normal visual field (previously found to have a nasal step)                           Yes     0                                                                                     0                                                                                                                

  Pituitary stalk lesion                                                       8                                                                                     Right   Normal visual field                                                                   Yes                                 0                                                                            0

  Left                                                                         Normal visual field                                                                   No      0                                                                                     1                                                                                                                

  Craniopharyngioma treated with cyst decompression and photon therapy         14                                                                                    Right   Normal visual field                                                                   No                                  0                                                                            1

  Left                                                                         Normal visual field                                                                   No      0                                                                                     1                                                                                                                

  Langerhans cell histiocytosis with lesions in the base of skull and orbits   12                                                                                    Right   Normal visual field                                                                   Yes                                 0                                                                            0

  Left                                                                         Enlarged blind spot                                                                   Yes     1                                                                                     1                                                                                                                

  Transverse myelitis with optic neuritis and disc pallor                      7                                                                                     Right   Normal visual field                                                                   No                                  0                                                                            3

  Left                                                                         Mild reduction in central visual field sensitivity                                    Yes     1                                                                                     2                                                                                                                

  Acute myeloid leukaemia (AML) and BIH                                        12                                                                                    Right   Normal visual field                                                                   Yes                                 0                                                                            0

  Left                                                                         Mild isopter constriction, with enlargement of the blind spot                         No      1                                                                                     0                                                                                                                

  IIH                                                                          11                                                                                    Right   Mild isopter constriction                                                             No                                  1                                                                            0

  Left                                                                         Normal visual field                                                                   Yes     0                                                                                     0                                                                                                                

  Suprasellar epidermoid cyst                                                  11                                                                                    Right   Normal visual field                                                                   Yes                                 0                                                                            0

  Left                                                                         Small nasal step, with grossly enlarged blind spot                                    Yes     2                                                                                     2                                                                                                                

  Craniopharyngioma treated with proton beam therapy                           9                                                                                     Right   Mild reduction in central visual field sensitivity, with an enlarged blind spot       Yes                                 1                                                                            1

  Left                                                                         Mild reduction in central visual field sensitivity, with an enlarged blind spot       Yes     1                                                                                     1                                                                                                                

  Craniopharyngioma (partially resected)                                       9                                                                                     Right   Mild reduction in central visual field sensitivity, with an enlarged blind spot       Yes                                 1                                                                            1

  Left                                                                         Mild reduction in central visual field sensitivity, with an enlarged blind spot       Yes     1                                                                                     1                                                                                                                

  Left optic nerve glioma                                                      12                                                                                    Right   Enlarged blind spot                                                                   Yes                                 1                                                                            3

  Left                                                                         Mild isopter constriction, with an enlarged blind spot                                Yes     1                                                                                     2                                                                                                                

  IIH                                                                          13                                                                                    Right   Mild isopter constriction                                                             No                                  1                                                                            1

  Left                                                                         Mild isopter constriction                                                             No      1                                                                                     1                                                                                                                

  Secondary raised intracranial pressure (ICP) after steroids                  10                                                                                    Right   Mild reduction in central visual field sensitivity                                    NA                                  1                                                                            NA

  Left                                                                         Mild isopter constriction (superior)                                                  NA      1                                                                                     NA                                                                                                               

  Papilloedema                                                                 5                                                                                     Right   Mild reduction in central visual field sensitivity                                    Yes                                 1                                                                            1

  Left                                                                         Mild reduction in central visual field sensitivity                                    NA      1                                                                                     NA                                                                                                               

  Pontine cavernoma                                                            11                                                                                    Right   Mild reduction in central visual field sensitivity                                    No                                  1                                                                            0

  Left                                                                         Mild reduction in central visual field sensitivity                                    No      1                                                                                     0                                                                                                                

  Low-grade glioma                                                             13                                                                                    Right   Enlarged blind spot                                                                   No                                  1                                                                            0

  Left                                                                         Mild reduction in central visual field sensitivity, with enlarged blind spot          No      1                                                                                     0                                                                                                                

  IIH                                                                          14                                                                                    Right   Moderate isopter constriction, with enlarged blind spot                               Yes                                 1                                                                            2

  Left                                                                         Moderate isopter constriction, with enlarged blind spot                               Yes     2                                                                                     2                                                                                                                

  IIH                                                                          14                                                                                    Right   Moderate reduction in central visual field sensitivity, with enlarged blind spot      Yes                                 2                                                                            2

  Left                                                                         Moderate reduction in central visual field sensitivity, with enlarged blind spot      Yes     2                                                                                     2                                                                                                                

  Right optic nerve glioma                                                     8                                                                                     Right   Moderate isopter constriction (nasal step), with an enlarged blind spot               Yes                                 2                                                                            2

  Left                                                                         Normal visual field                                                                   No      0                                                                                     1                                                                                                                

  Chiari I malformation                                                        10                                                                                    Right   Moderate isopter constriction, with enlarged blind spot                               Yes                                 3                                                                            3

  Left                                                                         Mild isopter constriction, with enlarged blind spot                                   No      1                                                                                     0                                                                                                                

  Medulloblastoma                                                              10                                                                                    Right   Mild/moderate isopter constriction, with isopter I2e inside 20°                       Yes                                 2                                                                            2

  Left                                                                         Moderate isopter constriction, with a nasal step                                      Yes     3                                                                                     2                                                                                                                

  Pilocytic brainstem astrocytoma with a paramacular scar                      10                                                                                    Right   Moderate isopter constriction, with isopter I2e inside 20°                            Yes                                 2                                                                            1

  Left                                                                         Moderate isopter constriction, with isopter I2e inside 20°                            Yes     2                                                                                     2                                                                                                                

  Posterior fossa astrocytoma (resected) with a left IV cranial nerve palsy    9                                                                                     Right   Moderate isopter constriction, with isopter I2e inside 10°                            No                                  3                                                                            1

  Left                                                                         Moderate isopter constriction, with isopter I2e inside 20°                            No      2                                                                                     1                                                                                                                

  Arachnoid cyst---tilted discs with bilateral peripapillary atrophy           9                                                                                     Right   Moderate reduction in central visual field sensitivity, with isopter I2e inside 10°   Yes                                 3                                                                            2

  Left                                                                         Moderate reduction in central visual field sensitivity, with isopter I2e inside 10°   Yes     3                                                                                     2                                                                                                                

  Grade I ganglioglioma (left cerebellum). Posterior fossa craniotomy          11                                                                                    Right   Moderate isopter constriction                                                         Yes                                 3                                                                            3

  Left                                                                         Moderate isopter constriction, with a right hemifield defect                          No      4                                                                                     3                                                                                                                

  Cervical meningocele with hydrocephalus and Chiari II malformation           13                                                                                    Right   Severe isopter constriction                                                           Yes                                 4                                                                            4

  Left                                                                         Severe isopter constriction                                                           Yes     4                                                                                     4                                                                                                                

  Epilepsy (lobectomy)                                                         15                                                                                    Right   Right homonymous hemianopia                                                           Yes                                 4                                                                            4

  Left                                                                         Right homonymous hemianopia                                                           Yes     4                                                                                     4                                                                                                                

  Glioma (occipital lobe high grade)                                           11                                                                                    Right   Left homonymous hemianopia                                                            Yes                                 4                                                                            4

  Left                                                                         Left homonymous hemianopia                                                            Yes     4                                                                                     4                                                                                                                
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Shaded cells represent comparisons in those with good Examiner Based Assessment of Reliability (EBAR) ratings for Goldmann and Octopus perimetry (n=42).

\*As recorded with Goldmann perimetry.

BIH, benign intracranial hypertension; NA, not applicable; VP, ventriculoperitoneal shunt.

Feasibility of perimetry {#s3-1}
------------------------

One subject completed only Goldmann perimetry before withdrawing. Two children required rest breaks during Goldmann perimetry and were subsequently unable to complete Octopus perimetry. 27/30 participants (90%) completed the Goldmann assessment in full, but in 3/30 (10%) the blind spot could not be plotted due to poor cooperation. 22/29 (75.9%) completed the Octopus assessment in full ([table 2](#T2){ref-type="table"}), but in 5, the blind spot could not be plotted due to poor cooperation. In one of these children a KPRM could not be plotted and in another testing was terminated due to fatigue. In addition, one child with Goldmann and two with Octopus perimetry had unreliable blind spot assessments. Thus, there were 4 (13%) and 7 (24%) either missing or unreliable blind spot plots for Goldmann and Octopus perimetry, respectively. Children with hemifield defects were noted to use intermittent search strategies to explore their non-seeing field.

###### 

Test feasibility and quality for Goldmann (n=30) and Octopus perimetry (n=29)

  Age group (years)   Number completing assessments (%)   Median test duration\* (min) (IQR)   Test quality† (EBAR rating) (%)                                                                                      
  ------------------- ----------------------------------- ------------------------------------ --------------------------------- ------------- ------------ -------------- ------------- ------------- ------------ ------------
  5--7 (n=5)          4 (80)                              3 (60)                               16 (14, 17)                       16 (15, 17)   4 (80)       2 (40)         1 (20)        1 (20)        0            2 (40)
  8--11 (n=15)‡       14 (93.3)                           10 (66.7)                            18 (16, 19)                       17 (15, 19)   13 (86.7)    13 (92.9)      2 (13.3)      1 (7.1)       0            0
  12--15 (n=10)       9 (90)                              9 (90)                               17.5 (16, 19)                     18 (15, 19)   7 (70)       7 (70)         2 (20)        3 (30)        1 (10)       0
  All ages            27/30 (90)                          22/29 (75.9)                         17 (16, 19)                       17 (15, 19)   24/30 (80)   22/29 (75.9)   5/30 (16.7)   5/29 (17.2)   1/30 (3.3)   2/29 (6.9)

\*Test duration values include preparation and assessment tasks and include those children who failed to complete assessments

†Test quality ratings include those who failed to complete assessments in full.

‡n=14 for Octopus perimetry.

Test duration was similar for both tests (t-test, n=29, mean difference: 0.48 min (−1.2, 2.2), p=0.559), and did not vary with increasing age for either Goldmann (−0.02 min/year (−0.50, 0.47), p=0.939) or Octopus perimetry (0.43 (−0.19, 1.04) min/year, p=0.164) ([table 2](#T2){ref-type="table"}). Isopter area, VA, sex and ethnicity were not associated with test duration for either perimeter (univariable analyses).

Quality of perimetry {#s3-2}
--------------------

Quality ratings are shown in [table 2](#T2){ref-type="table"} (Goldmann, n=30; Octopus, n=29). Failure to complete full testing was associated with poorer quality (ie, not 'good' EBAR) in 3/3 (100%) children for Goldmann and 3/7 (43%) children for Octopus perimetry---reflecting, for Octopus perimetry, the small number of otherwise cooperative children in whom the blind spot could not be plotted.

Test quality (EBAR) was similar for Goldmann and Octopus perimetry for children ≥8 years (McNemar's test, χ^2^=1.0, p=0.317). Children under 8 years demonstrated better quality results with Goldmann (4/5, 80% good EBAR) than Octopus perimetry (2/5, 40% good EBAR).

4/30 (13%) and 10/29 (34%) demonstrated fatigue during Goldmann and Octopus perimetry, respectively. 7/29 (24%) children responded to the sound of stimulus presentation during Octopus perimetry, with 2/29 children (6.9%) sufficiently distracted to affect test quality.

The KPRM was implemented in 57/58 (98%) eyes completing full testing. KPRM values increased (ie, worsened) with poorer test quality for Goldmann (adjusted OR: 4.0 (2.1, 5.9), good vs combined fair and poor quality), but not Octopus perimetry (1.4 (−0.7, 3.6), p=0.178) ([table 3](#T3){ref-type="table"}).

###### 

Median kinetic perimetry reliability measure (KPRM) values by EBAR quality scores for Goldmann and Octopus kinetic perimetry in all participants

  EBAR rating   Median KPRM (IQR)   
  ------------- ------------------- ----------------
  Good          1.8 (1.2, 3.8)      2.7 (2.2, 4.3)
  Fair          7.4 (4.6, 9.1)      4.5 (3, 7.4)
  Poor          6.8 (5.4, 8.3)\*    NA†

\*Values indicate data range.

†Those with poor-quality Octopus results (n=2) were unable to plot a KPRM.

EBAR, Examiner Based Assessment of Reliability; NA, not applicable.

Test outputs {#s3-3}
------------

Goldmann and Octopus VF loss severity scores showed broad agreement (κ=0.65 (SE=0.10), n=21, good 'EBAR' only, [table 4](#T4){ref-type="table"}). Scores were identical in 24/42 tests (57%) with 11/18 (61.1%) non-identical scores being lower (ie, less severe VF loss) for Octopus. All non-identical tests scored ≥2 with Goldmann perimetry had a lower Octopus score but discordance was \>1 in only 1/42 (2.4%) test. Goldmann and Octopus outputs matched with respect to type of field defect in 29/42 (69%) tests.

###### 

Comparison of Goldmann and Octopus classification scores

  Goldmann classification score   Octopus classification score   Total eyes                
  ------------------------------- ------------------------------ ------------ ---- --- --- ----
  0                               9                              4            0    0   0   13
  1                               6                              5            1    0   0   12
  2                               0                              2            7    0   0   9
  3                               0                              1            3    1   0   5
  4                               0                              0            0    1   2   3
  Total eyes                      15                             12           11   2   2   42

Shaded areas represent equivalent scores. Only participants who have 'good' Examiner Based Assessment of Reliability (EBAR) scores on both tests are shown here (n=21).

On average, Octopus outputs depicted more extensive fields (ie, less VF loss); mean difference −514.3 deg^2^ (−817.4, --211.2) and −575.5 deg^2^ (−900.1, --250.9) for isopters I4e and I2e, respectively. On average, using Goldmann, blind spot area was 20.8 deg^2^ (5.7, 35.8) larger. Bland-Altman analysis ([online supplementary efigure 1A--C](#SP1){ref-type="supplementary-material"}) showed modest agreement for the blind spot and smaller Goldmann area measures with both isopters, although limits of agreement were wide with increasing variation as average isopter area increased.
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Blind spot size (using Goldmann perimetry) was larger for those with classification scores ≥1 compared with those with score 0 ([table 5](#T5){ref-type="table"}).

###### 

Blind spot size for classification scores of 0 or higher in participants with 'good' quality tests

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                          Goldmann classification score   Octopus classification score                                               
  --------------------------------------- ------------------------------- ------------------------------ --------------- -------------- ------------ ---------------
  Median blind spot size (deg^2^) (IQR)   76.4\                           84.5\                          113.6\          60.8\          79\          75.5\
                                          (61.4, 94.7)                    (72.6, 94.3)                   (86.2, 147.7)   (41.9, 80.6)   (68, 97.5)   (53.9, 135.5)

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Reference values are based on age-appropriate normative data.[@R13]

Self-report of examination experience {#s3-4}
-------------------------------------

Only two children reported Goldmann perimetry to be 'hard'. All other tests (n=57) were scored as 'OK' (Goldmann, n=11 (41%), Octopus, n=14 (52%)), 'easy' (Goldmann, n=7 (26%), Octopus, n=10 (37%)) or 'very easy' (Goldmann, n=7 (26%), Octopus, n=3 (11%)). Eight children preferred Octopus perimetry, citing newer/computerised technique, more reliable/different buzzer, more visible stimuli (n=3) and central fixation point (n=2) and more comfortable chinrest.

Discussion {#s4}
==========

We report a comparison of Goldmann and Octopus perimetry in children with diverse neuro-ophthalmic disorders, showing similar test duration for all ages, and similar quality in children over 8 years. Test quality did not improve with increasing age. Though both tests delineated neuro-ophthalmic VF defects, in many children neither the severity of VF loss nor type of defect depicted concorded between perimeters. Thus, although Goldmann and Octopus perimeters are similar in specification, their outputs are not directly interchangeable in this heterogeneous population.

Our study sample intentionally excluded children in whom formal perimetry would be precluded. Children were under active clinical monitoring, necessitating capturing of Goldmann perimetry and precluding test order randomisation which potentially introduced bias through fatigue and/or learning effects. However, quality ratings were only better for the first test in children under 8 years of age and test completion rates followed similar trends to those previously reported in children without ophthalmic disease (90% vs 96.1% for Goldmann and 75.9% vs 89% for Octopus perimetry).[@R14] A single examiner with expertise in perimetry undertook all the tests to avoid interexaminer variability. This examiner was unmasked to the participants' initial defect. Subsequent grading (as a separate exercise and without reviewing clinical details) of the recorded VF defects was also undertaken by one unmasked examiner using classification systems that do not include subjective interpretation.

We used the EBAR[@R14] and KPRM[@R16] metrics, our recently developed standardised measures of kinetic perimetry quality. EBAR scores show good agreement with static automated indices[@R14] and KPRM ratings allow quantifiable documentation of test-retest variability, and thus aid interpretation of repeated testing over time. The ability to differentiate true change in VF sensitivity versus fluctuations in test quality is clinically significant: in the absence of automated reliability indices for kinetic perimetry, combined use of EBAR and KPRM scoring systems may help.

While complete agreement between Goldmann and Octopus perimetry regarding extent of VF loss may not be absolutely essential, our finding that Octopus perimetry may underestimate the most severe VF defects is important. Since differences between the two perimeters were also isopter sensitive, it is not recommended to use perimeters interchangeably when monitoring children longitudinally. Thus, if replacing Goldmann with Octopus perimetry, clinicians will need to develop appropriate strategies to transition patients, and interpret findings against perimeter-specific normative values. Further research is required to increase knowledge about monitoring progression with Octopus perimetry.

Inability to accurately plot blind spots was more common with Octopus perimetry even when far-peripheral testing was successful. Assessment of isolated blind spot defects can be of primary interest but also add nuanced interpretation of perimetry outputs.

Participants were less affected by the noise of Octopus perimetry than reported previously by children without field defects (11% vs 6.9%)[@R14] and commonly preferred Octopus perimetry. However, preference for test modality is not necessarily associated with better test quality.[@R14] Contrary to findings in normative populations[@R15] and children with glaucoma,[@R26] test duration did not decrease with increasing age, possibly reflecting the challenges of assessing and characteristics of children with complex neurological conditions.

Our findings show the importance of stringent control of fixation, especially in patients with hemifield defects who have potential for recovery of field loss.[@R27] Kinetic perimetry, pausing presentation of stimuli until fixation is restored, can improve accuracy of testing, mitigating fixation losses and search strategies.

There are no previous studies of conventional kinetic perimetry in a heterogeneous population of children with all-cause neuro-ophthalmic disease against which we can compare directly our findings. Early identification of VF loss is highly important but remains challenging in children in whom conventional perimetry is not possible, and for those too young to cooperate with testing. Attention needs to be directed to developing and refining approaches which allow early detection of gross defects including approaches that are showing promise in the evaluation of young children.[@R28] Non-quantifiable or suprathreshold tests have merit in this regard but are limited with respect to their ability to act as a 'baseline' assessment for monitoring progressive VF loss in those who can be expected to be able to perform full formal perimetry later in childhood. We suggest future research should be directed at identifying the elements of kinetic perimetry with greatest diagnostic value in specific conditions, to develop disorder-specific protocols that maximise utility while minimising burden of testing. Our generic findings should inform the design of such research.

Static perimetry has poor sensitivity for detecting subtle peripheral neuro-ophthalmic defects.[@R31] Large defects should be detectable by static perimetry, though limited evidence exists about the effect of algorithm 'optimisation' for glaucoma, and thus we suggest kinetic perimetry is preferable for neuro-ophthalmic defects of any severity.[@R32]

Our findings in a heterogeneous group of children with neuro-ophthalmic disease able to cooperate with formal testing support attempting either Octopus or Goldmann kinetic perimetry in children ≥8 years of age, with the expectation of meaningful outputs in most. However, clinicians should be mindful that outputs are not directly interchangeable, and that differences are greatest with the most severe VF loss, with implications for transitioning from Goldmann to Octopus perimeters.

We are grateful to Haag-Streit (Switzerland) for the loan of an Octopus perimeter to Great Ormond Street Hospital for this study.
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